Rate of Curative Surgery in Real-world Patients with Unresectable Metastatic Colorectal Cancer Treated with FOLFOXIRI ± Bevacizumab: A Western Canadian Province Experience.

Tayyaba BhattiMichael MoserKiat Tsong TanHaji ChalchalOsama SouiedDuc LeJohn ShawAdnan ZaidiDilip GillShahid Ahmed

Published in: Journal of gastrointestinal cancer (2021)

The current study suggests that FOLFOXIRI ± bevacizumab therapy in real-world patients with mCRC is associated with a high rate of conversion from unresectable to resectable metastatic disease. Patients with metastasectomy had better survival.

Keyphrases

metastatic colorectal cancer
locally advanced
liver metastases
south africa
rectal cancer
squamous cell carcinoma
minimally invasive
small cell lung cancer
stem cells
free survival
mesenchymal stem cells
atrial fibrillation
surgical site infection